Sign up for our eNews and discover more about what we're up to, the difference we're making, and, most importantly, how you can help.
Thursday 11 January 2018
Dementia Australia is dismayed that Pfizer, the world’s third largest drug maker, has announced this week that it will end its research to discover new medications for Alzheimer’s disease.
Dementia Australia CEO, Maree McCabe, said that research into dementia and Alzheimer’s disease was a key element in addressing the impact that dementia has on our communities.
“The only way we will develop any effective medical treatments, or even develop a way to prevent or halt dementia, is through both public and private investment in research,” she said.
“Every three seconds someone in the world develops dementia and it is more important than ever that both governments and private organisations invest in dementia research.”
Dementia is the second leading cause of death of Australians. In 2016, dementia became the leading cause of death among Australian women, surpassing heart disease, which had been the leading cause of death for both males and females since the early twentieth century.
There are more than 425,000 Australians living with dementia and this is set to increase to 1.1 million people by 2056.
Ms McCabe said investment in research was vital to find a cure, especially with the prevalence of dementia in our community.
“Without a medical breakthrough the number of people with dementia in Australia is expected to increase,” she said.
“It is disheartening for people impacted by dementia to hear that Pfizer has made this decision. It is essential that there is ongoing investment into drug-based treatments for dementia, alongside other innovative forms of dementia research – the potential benefits of success will significantly impact the hundreds of thousands of Australians living with dementia now and in the future.”
Dementia Australia is the national peak body and charity for people, of all ages, living with all forms of dementia, their families and carers. It provides advocacy, support services, education and information. An estimated 436,000 people have dementia in Australia. This number is projected to reach almost 1.1 million by 2058. Dementia Australia is the new voice of Alzheimer’s Australia. Dementia Australia’s services are supported by the Australian Government.
National Dementia Helpline 1800 100 500
Interpreter service available
(The National Dementia Helpline is an Australian Government Initiative)
Dementia is a National Health Priority Area
When talking or writing about dementia please refer to Dementia Language Guidelines.
More media releases
Dementia peak body thanks aged care workers on Aged Care Employee Day
On Aged Care Employee Day, Dementia Australia acknowledges the hundreds of thousands of people working in the industry across Australia. Dementia Australia CEO Maree McCabe said the day is an opportunity to thank, honour and celebrate aged care employees, which are now more important than ever.
Aged care sector backs quality dementia care action plan
Leadership, culture change, building workforce capacity and continuous improvement are the essential elements to ensuring quality care for people living with dementia, prioritised in Dementia Australia’s Quality Care Initiative Action Plan released today. Dementia Australia CEO Maree McCabe said this Action Plan represents a consensus view of thought-leaders across the aged care sector.
Ita Buttrose AC OBE encourages aged care sector to join free dementia webinars
Dementia Australia’s National Ambassador Ita Buttrose AC OBE has invited aged care professionals to register for the Dementia Australia National Symposium Series 2020 – Dementia care is quality care. Ms Buttrose said she will present at the final session of the online weekly webinar series, which will be held for six consecutive weeks starting Tuesday 4 August.